PBAC Public Summary Documents – March 2017

Page last updated: 20 September 2017

Public Summary Documents relating to the March 2017 PBAC meeting.

• Abiraterone: Tablet 250 mg; Zytiga®
• Adalimumab: Injection 40 mg in 0.8 mL pre-filled syringe, Injection 40 mg in 0.8 mL pre-filled pen; Humira®
• Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides: Oral powder 400 g; Neocate Junior®
• Amino acid formula with vitamins and minerals without phenylalanine: Oral liquid 130 mL, 30, Oral liquid 174 mL, 30; PKU Air®
• Amino acid formula with vitamins and minerals without phenylalanine: Oral liquid 87 mL, 30, Oral liquid 130 mL, 30, Oral liquid 174 mL, 30; PKU Cooler®
• Amino acid formula with vitamins and minerals without phenylalanine and tyrosine: Sachets containing oral powder 34 g, 30; TYR Express20®
• Amino acid formula with vitamins and minerals, without phenylalanine, and supplemented with docosahexaenoic acid and arachidonic acid: Sachets containing oral powder 12.5 g, 30; PKU Anamix First Spoon®
• Apremilast: Tablet 30 mg, Pack containing 4 tablets 10 mg, 4 tablets 20 mg and 19 tablets 30 mg; Otezla®
• Botulinum toxin type A: Lyophilised powder for injection 100 units; Botox®
• Brexpiprazole: Tablet 1 mg, Tablet 2 mg, Tablet 3 mg, Tablet 4 mg; Rexulti®
• Brivaracetam: Tablet 25 mg, Table 50 mg, Tablet 75 mg, Tablet 100 mg, Oral suspension 10 mg per mL, 300 mL; Briviact®
• Certolizumab pegol: Injection 200 mg in 1 mL single dose auto-injector; Cimzia®
• Chorionic gonadotropin: Injection set containing 3 vials powder for injection 1,500 units and 3 vials diluent 1 mL, Injection set containing 1 vial powder for injection 5,000 units and 1 vial diluent 1 mL; Pregnyl®
• Crizotinib: Capsule 200 mg, Capsule 250 mg; Xalkori®
• Degarelix: Powder for injection 80 mg (as acetate), injection set,  Powder for injection 120 mg (as acetate), injection set; Firmagon®
• dTpa Vaccine: Single dose vial containing 0.5 mL of vaccine; Adacel®
• Empagliflozin with linagliptin: Tablet containing 10 mg empagliflozin with 5 mg linagliptin; Tablet containing 25 mg empagliflozin with 5 mg linagliptin; Glyxambi®
• Enzalutamide: Capsule 40 mg; Xtandi®
• Fluticasone furoate: Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose;Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose; Arnuity Ellipta®
• Goserelin: 3.6 mg implant; Zoladex Implant®
• Mesalazine: Tablet (enteric coated) 800 mg ; Asacol®
• Methotrexate: Injection 7.5 mg in 0.15 mL pre-filled syringe, Injection 10 mg in 0.2 mL pre-filled syringe, Injection 15 mg in 0.3 mL pre-filled syringe, Injection 20 mg in 0.4 mL pre-filled syringe, Injection 25 mg in 0.5 mL pre-filled syringe; Trexject®
• Migalastat: Capsule 150 mg; Galafold®
• Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
• Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
• Nivolumab and Ipilimumab: Nivolumab:  Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®. Ipilimumab:  Injection concentrate for I.V. infusion 50 mg in 10 mL, Injection concentrate for I.V. infusion 200 mg in 40 mL; Yervoy®
• Palbociclib: Capsule 75 mg, Capsule 100 mg, Capsule 125 mg; Ibrance®
• Pembrolizumab: Injection concentrate for I.V. infusion 100 mg in 4 mL, Powder for injection 50 mg; Keytruda®
• Pomalidomide: Capsule 3 mg, Capsule 4 mg; Pomalyst®
• Ranolazine: Tablet (modified release) 375 mg, Tablet (modified release) 500 mg, Tablet (modified release) 750 mg; Ranexa®
• Rituximab: Solution for subcutaneous injection 1600 mg in 13.4 mL; MabThera SC®
• Selexipag: Tablet 200 mcg, Tablet 200 mcg, Tablet 400 mcg, Tablet 600 mcg, Tablet 800 mcg, Tablet 1000 mcg, Tablet 1200 mcg, Tablet 1400 mcg, Tablet 1600 mcg; Uptravi®
• Tenofovir alafenamide: Tablet 25 mg; Vemlidy®
• Tolvaptan: Tablet 15 mg, Tablet 30 mg, Pack containing 28 tablets 15 mg and 28 tablets 45 mg, Pack containing 28 tablets 30 mg and 28 tablets 60 mg, Pack containing 28 tablets 30 mg and 28 tablets 90 mg; Jinarc®
• Trifluridine with tipiracil: Tablet containing 15 mg trifluridine with 6.14 mg tipiracil (as hydrochloride), Tablet containing 20 mg trifluridine with 8.19 mg tipiracil (as hydrochloride); Lonsurf®
• Triglycerides long chain, 2. Triglycerides medium chain: 1. Oral liquid 250 mL, 18, 2. Oral liquid 250 mL, 18; 1. CarbZero®, 2. Betaquik®
• Ulipristal (as acetate): Tablet 5 mg; Esmya®
• Ursodeoxycholic acid: Tablet 500 mg; Ursofalk®
• Ustekinumab: Injection concentrate for I.V. infusion 130 mg in 26 mL, Injection 45 mg in 0.5 mL; Stelara®
• Venetoclax: Tablet 10 mg, Tablet 50 mg, Tablet 100 mg; Venclexta®
• Vorinostat: Capsule 100 mg; Zolinza®